Myoung‐don Oh - Concepedia

Author

Myoung‐don Oh

Seoul National University ORCID

Also Known As

F McLellan, Hang-Rae Kim, Hong Bin Kim, Hyun Mu Shin, Jae-Hwa Suh, Ji-Young Min, M D Oh, M. D. Oh, M. Oh, M.-D. Oh

474

Publications

29.1K

Citations

H-Index

170

Concepts

All Affiliations

Seoul National University Seoul National University Hospital Seoul National University Bundang Hospital New Generation University College SNUH SMG-SNU Boramae Medical Center

About

Myoung‐don Oh is an author at Seoul National University specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	97	6.5K
2	Health Sciences	19	20	2.7K
3	Public Health	16	18	506
4	Engineering	2	2	53
5	Nursing	1	1	31

Myoung‐don Oh

232

Publications

25.1K

Citations

H-Index

Page 1

	Year	Citations
Remdesivir for the Treatment of Covid-19 — Final Report John H. Beigel, Kay M Tomashek, Lori E. Dodd, New England Journal of Medicine	2020	7.6K
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta, New England Journal of Medicine	2020	1.9K
COVID-19: towards controlling of a pandemic Juliet Bedford, Delia Enría, Johan Giesecke, The Lancet	2020	1.6K
Severe Fever with Thrombocytopenia Syndrome, South Korea, 2012 Kye-Hyung Kim, Jongyoun Yi, Gayeon Kim, Emerging infectious diseases ThrombopoiesisThrombosisSfts VirusSfts Virus StrainsSevere Fever	2013	688
Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome Cheol‐In Kang, Sung‐Han Kim, Wan Beom Park, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeEscherichia Coli BacteremiaAntibiotic ResistanceDrug ResistanceAntimicrobial Stewardship	2005	685
<i>Pseudomonas aeruginosa</i>Bacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome Cheol‐In Kang, Sung‐Han Kim, Hong Bin Kim, Clinical Infectious Diseases Severe SepsisBacterial PathogensDelayed ReceiptDrug ResistanceAntimicrobial Stewardship	2003	566
The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures Jin Yong Kim, Pyoeng Gyun Choe, Yoonju Oh, Journal of Korean Medical Science	2020	422
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial Wan Beom Park, Nak‐Hyun Kim, Seung Hwan Lee, Clinical Infectious Diseases	2012	384
Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19 Eu Suk Kim, Bum Sik Chin, Chang Kyung Kang, Journal of Korean Medical Science	2020	322
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial Kayvon Modjarrad, Christine C. Roberts, Kristin T Mills, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirology	2019	314

Page 1